Taiwan FDA registration 83764a847609cd34328e8fbcf7d08730
BD sodium citrate vacuum blood collection tubes
TW: BD檸檬酸鈉真空採血管
Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY·Registered Dec 02, 2020 – Dec 02, 2025ExpiredRegistration details
- Analysis ID
- 83764a847609cd34328e8fbcf7d08730
- Customs Code
- DHA05603416408
Company information
- Manufacturer
- BECTON DICKINSON AND COMPANY
- Manufacturer Country
- United Kingdom
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- This product can be used with a lancet and needle holder as a system for collecting venous blood. The purpose of this product is to deliver and process blood used in clinical laboratories to test serum, plasma or whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1675 Blood collection equipment
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Dec 02, 2020
- Expiry Date
- Dec 02, 2025
About this record
Access comprehensive regulatory information for BD sodium citrate vacuum blood collection tubes in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 83764a847609cd34328e8fbcf7d08730 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices